Cathepsin B expression is associated with arterial stiffening and atherosclerotic vascular disease
- 1 December 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 27 (19) , 2288-2291
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-studyAtherosclerosis, 2018
- Vascular ageing: Underlying mechanisms and clinical implicationsExperimental Gerontology, 2018
- Cathepsin B and L activity in the serum during the human aging processArchives of Gerontology and Geriatrics, 2012
- Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseasesCellular and Molecular Life Sciences, 2012
- Cysteine cathepsins: From structure, function and regulation to new frontiersBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012
- Protease Imaging of Human Atheromata Captures Molecular Information of Atherosclerosis, Complementing Anatomic ImagingArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Enhanced Myocardial Cathepsin B Expression in Patients with Dilated CardiomyopathyEuropean Journal of Heart Failure, 2006
- Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activityNephrology Dialysis Transplantation, 2003
- Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells.Rheumatology, 1997